Kinetic Estimated Glomerular Filtration Rate (keGFR)
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۰.۱ — حداکثر ۱۵ • واحد: mg/dL
حداقل ۰.۱ — حداکثر ۲۵ • واحد: mg/dL
حداقل ۰.۱ — حداکثر ۲۵ • واحد: mg/dL
حداقل ۱ — حداکثر ۱۶۸ • واحد: hours
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- —≥ 60
- —30–59
- —15–29
- —≤ 14
The Kinetic Estimated Glomerular Filtration Rate (keGFR) calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include age. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates GFR in patients with acutely changing creatinine levels, allowing for earlier detection of acute kidney injury when creatinine is in a non-steady state. More accurate than traditional GFR equations during periods of rapidly changing kidney function.
Clinical Indication
The Kinetic Estimated Glomerular Filtration Rate (keGFR) is indicated for bedside clinical practice to support Estimates GFR in patients with acutely changing creatinine levels, allowing for earlier detection of acute kidney injury when creatinine is in a non-steady state. More accurate than traditional GFR equations during periods of rapidly changing kidney function.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.
Limitations & Contraindications
eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.
Clinical Pearls & Action Plan
Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.
keGFR = eGFR_baseline - (Δcreatinine × Vd) / (time × BSA) where eGFR_baseline is calculated using MDRD equation, Δcreatinine = Cr2 - Cr1, Vd = distribution volume, BSA = body surface area
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| sex | string | Yes | Biological sex of the patient |
| race | string | Yes | Race for MDRD equation adjustment |
| baseline_creatinine | float | Yes | Baseline serum creatinine before acute illness (mg/dL). Use most recent stable value if available.(mg/dL) |
| creatinine_1 | float | Yes | First creatinine measurement (mg/dL)(mg/dL) |
| creatinine_2 | float | Yes | Second creatinine measurement (mg/dL)(mg/dL) |
| time_hours | float | Yes | Time between first and second creatinine measurements in hours(hours) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 60 | — | Normal/near-normal kidney function |
| 30–59 | — | Moderate kidney dysfunction |
| 15–29 | — | Severe kidney dysfunction |
| ≤ 14 | — | Kidney failure |
Evidence-Based References (EBM)
- Chen S. Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol. 2013 May;24(6):877-88.
- O'Sullivan ED, Doyle A. The clinical utility of kinetic glomerular filtration rate. Clin Kidney J. 2017 Apr;10(2):202-208.
- Pickering JW, Ralib AM, Endre ZH. Combining creatinine and volume kinetics identifies missed cases of acute kidney injury following cardiac arrest. Crit Care. 2013 Jan 14;17(1):R7.
- Dewitte A, Joannès-Boyau O, Sidobre C, Fleureau C, Bats ML, Derache P, et al. Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery. Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1900-10.